Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Novartis patents mutant CFTR correctors

July 14, 2020

Alzumab approved in India for emergency use to treat CRS in patients with COVID-19-related ARDS

July 13, 2020

Enrollment ongoing in phase I study of KBL-693

July 13, 2020

Humanwell Healthcare, Hubei Bio-Pharmaceutical patent PDE4 inhibitors

July 13, 2020

Angion begins phase II study in Brazil with ANG-3777 in patients with COVID-19 pneumonia

July 9, 2020

Immune Regulation and DynPort partner to advance IRL-201104 for COVID-19-related ARDS

July 7, 2020

European Commission approves Enerzair Breezhaler for uncontrolled asthma

July 7, 2020

Dimerix advances understanding of DMX-700 in COPD

July 7, 2020

CSL Behring initiates phase II study of CSL-312 for respiratory distress in patients with COVID-19

July 7, 2020

Results from phase II RELIEF study of BLU-5937 in refractory chronic cough

July 7, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 3, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 3, 2025.
Biopharma exempt from US reciprocal tariffs, but not untouched
BioWorld
At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...
Impact of Trump tariffs on med tech proving difficult to anticipate
BioWorld MedTech
The Trump administration’s declaration of a new round of tariffs did not sit well with trade associations, but the impact of those tariffs may vary somewhat by...
ADPD 2025: Unlocking GLP-1's potential in neurodegeneration
BioWorld
At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...